Another challenge for CSPG4-CAR-T-cell therapy of melanoma, derives from the presence of soluble CSPG4 in the bloodstream [70], which is generated by cleavage of the ectodomain of CSPG4 [31]. The gene discussed is CSPG4; the disease is melanoma.